EDN1 and metabolic syndrome: To support earlier findings above, Tesauro and coworkers [110] conducted a human study in persons with obesity and metabolic syndrome in order to test if exogenous ghrelin could improve the balance between NO and endothelin-1, a vasoconstrictor peptide produced by vascular endothelial cells.